Arcus Biosciences (RCUS) “announced that data from the ARC-20 study will be presented in a rapid oral session at the 2025 American Society of ...

Dr. Markus will oversee Arcus’s clinical development organization and portfolio that includes seven clinical-stage programs with multiple ongoing Phase 3 studies HAYWARD, Calif., January 21 ...

New data from ARC-20, a Phase 1/1b study of the HIF-2a inhibitor casdatifan in clear cell renal cell carcinoma (ccRCC), will be presented in a rapid oral session by Dr. Toni Choueiri, Dana-Farber ...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies ...

Arcus senilis is a white, gray, or blue arc or ring that develops around the edge of the cornea. It typically appears as an arc that affects the top and bottom of the cornea. According to the ...

HOUSTON, Jan. 28, 2025 /PRNewswire/ -- Arcus Advisors LLC, a leading business advisory firm specializing in private equity backed portfolio company solutions, today announced the launch of its ...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies ...